San Francisco 18 April 2019 Active Pharmaceutical Ingredient (API) Market Size, Share & Trends Analysis
Report By Type of Synthesis (Biotech, Synthetic), By Type of Manufacturer
(Captive, Merchant), By Application, By Region, And Segment Forecasts, 2019 -
2026
The global active pharmaceutical ingredient (API) market size is expected to reach at USD 268.12 billion by 2026
registering a CAGR of 6.8%, according to a new report by Grand View Research,
Inc. Rising trend of outsourcing APIs and growing prevalence of various target
diseases, such as cancer, Cardiovascular Disease (CVDs) are anticipated to
boost the market. Huge capital is required in API production as the process
needs extremely systematic protocols. Pharmaceutical companies can actually
benefit from outsourcing API production, as it eliminates the need for
installing expensive manufacturing units. Moreover, strategic outsourcing
enables companies to focus on their core competencies, ultimately resulting in
increased productivity. These factors are also estimated to drive the demand in
future.
Growing geriatric population across the
globe is also likely to contribute to the market expansion. Estimates published
by the WHO suggest that the global base of population pertaining to the age
group of 65 years and above is expected to rise from 7% in 2000 to 16% in 2050.
Latin America, in particular, is projected to witness fastest growth, in terms
of geriatric population, followed by Asia (66%), Africa (64%), North America
(41%), and Europe (23%). Patent expiration of blockbuster drugs, growing outsourcing
activities due to high manufacturing costs, and stringent regulations for API
production are expected to intensify the market competition. As part of
strategic geographic expansion, many companies are setting up manufacturing
plants in the developing regions like Asia Pacific.
Access Research Report of Active
Pharmaceutical Ingredient Market @ https://www.grandviewresearch.com/industry-analysis/active-pharmaceutical-ingredients-market
Further key findings from the study suggest:
· Synthetic APIs held the largest share of
the API market in 2018 owing to easy availability of raw materials and easier
protocols for synthesis of these molecules
· Biotech APIs are estimated to register the
highest CAGR over the forecast years due to rising demand for
biopharmaceuticals and higher efficiency of these molecules
· Captive manufacturers led the market owing
to intensive capitalization of major key players in development of high-end
manufacturing facilities
· Merchant manufacturers segment is expected
to be the fastest-growing segment over the forecast period
· Generic APIs are expected to register a
lucrative CAGR over the forecast period on account of factors, such as
expiration of patents of branded drugs and lower cost
· Cardiology segment led the overall market
in 2018. Increasing prevalence of target diseases worldwide and high demand for
fast-acting drugs are some of the key factors responsible for the segment
growth
· North America held the largest market share
in 2018. Asia Pacific is estimated to be the fastest-growing region expanding
at a CAGR of 8.2% over the estimated period
· Some of the major companies in the market
are Teva Pharmaceutical Industries Ltd.; AbbVie Inc.; Boehringer Ingelheim
International GmbH; Cipla Inc.; Merck & Co., Inc.; Bristol-Myers Squibb
Company; Albemarle Corporation; Mylan N.V.; Aurobindo Pharma; Sun
Pharmaceutical Industries Ltd.; and Dr. Reddy’s Laboratories Ltd.
Browse more reports of this category by Grand View
Research at: https://www.grandviewresearch.com/industry/pharmaceuticals
Grand View Research has
segmented the global Active Pharmaceutical Ingredient (API) market on the basis
of type of synthesis, type of manufacturer, type, application, and region:
API Type of Synthesis Outlook
(Revenue, USD Billion, 2014 - 2026)
·
Biotech
·
Synthetic
API Type of Manufacturer Outlook
(Revenue, USD Billion, 2014 - 2026)
·
Captive
·
Merchant
API Type Outlook (Revenue, USD Billion,
2014 - 2026)
·
Generic
·
Innovative
API Application Outlook (Revenue, USD
Billion, 2014 - 2026)
·
Cardiology
·
Oncology
·
CNS & Neurology
·
Orthopedic
·
Endocrinology
·
Pulmonology
·
Gastroenterology
·
Nephrology
·
Ophthalmology
·
Others
API Regional Outlook (Revenue, USD
Billion, 2014 - 2026)
·
North America
·
Europe
·
Asia Pacific
·
Latin America
·
MEA
Access Press Release of
Active
Pharmaceutical Ingredient Market@ https://www.grandviewresearch.com/press-release/global-active-pharmaceutical-ingredients-api-market
About
Grand View Research
Grand
View Research, Inc. is a U.S. based market research and consulting company,
registered in the State of California and headquartered in San Francisco.
The company provides syndicated research reports, customized research
reports, and consulting services. To help clients make informed business
decisions, we offer market intelligence studies ensuring relevant and
fact-based research across a range of industries, from technology to chemicals,
materials and healthcare.
No comments:
Post a Comment